
Mikaject 250mg Injection
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Amikacin (250mg)
Overview Mikaject 250mg Injection
Cefamandole 250mg injection combats a broad spectrum of bacterial infections, including those affecting the urinary system, skeletal system, respiratory system (like pneumonia), central nervous system, and circulatory system, among others. Prophylactic use is common in hospitalized patients. This antibiotic halts bacterial proliferation. Administration, via intravenous infusion or intramuscular/intravenous injection, requires professional medical oversight and should never be self-administered. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Completing the entire course is vital; premature cessation may result in relapse or infection exacerbation. Minor side effects can manifest as injection site reactions and elevated blood urea nitrogen levels. Persistent symptoms or treatment inefficacy warrant immediate medical consultation. High doses may, in some cases, cause vertigo, nephropathy, and hearing impairment. Therefore, diligent adherence to physician instructions is paramount. Regular monitoring, including kidney function, hearing, and urinalysis, may be implemented. Use during pregnancy is contraindicated; disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Mikaject 250mg Injection
Infections caused by bacteria
Major Benefits of Mikaject 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikaject 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikaject 250mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Mikaject 250mg Injection works:
Microbial growth is inhibited by the antibiotic Mikaject 250mg Injection, which acts by disrupting the production of vital bacterial proteins.
SAFETY ADVICE
AlcoholSAFE
Mikaject 250mg Injection does not interact negatively with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mikaject 250mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards, as determined by a physician. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Mikaject 250mg Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Mikaject 250mg Injection could lead to drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administration of Mikaject 250mg Injection requires careful monitoring. Dosage modification of Mikaject 250mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mikaject 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mikaject 250mg Injection :
Omit a Mikaject 250mg Injection dose? Seek medical advice immediately.
Facts to Know About Mikaject 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
| Behavioral Class | Aminoglycoside antibiotics |
